title: ALK-targeted therapy for poor-prognosis childhood cancers.
authors.affiliation: Clinical Research Programme, Spanish National Cancer Research Centre, CNIO, Melchor Fernandez Almagro 3, 28029 Madrid, Spain. lmorenom@cnio.es
authors.forename: Lucas
authors.initials: L
authors.lastname: Moreno
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077547:Crizotinib; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy*; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib